Literature DB >> 3475522

Plasma and lipoprotein fatty acid composition in glycogen storage disease type I.

E Levy, J Letarte, G Lepage, L Thibault, C C Roy.   

Abstract

Nocturnal intragastric feeding has been shown to be an effective means to improve clinical and biochemical features in glycogen storage disease type I (GSD-I). In this study, we investigated the fatty acid patterns in a whole plasma and in circulating lipoproteins in patients on this therapy. The results demonstrated massive concentration of total fatty acids coupled with higher levels of triglycerides, free cholesterol, cholesterol ester and phospholipids. This hyperlipidemia involved all fatty acids without distinction of carbon or bond numbers. However, the increase was more pronounced for saturated than polyunsaturated fatty acids, as was demonstrated by the ratios of both oleic acid to linoleic acid (1.91 +/- 0.40 vs 0.80 +/- 0.09 in controls) and of omega 3 + omega 6 to omega 9 fatty acid families (0.92 +/- 0.11 vs 1.66 +/- 0.08 in controls). The fatty acid patterns in very low (VLDL), low (LDL) and high (HDL) density lipoprotein showed substantial differences in composition, reflecting an association between an abnormal lipoprotein pattern and essential fatty acid deficiency. Furthermore, GSD-I patients exhibited a significant increase in VLDL (17 +/- 2 vs 47 +/- 7 mg/dl) and LDL cholesterol (124 +/- 7 vs 206 +/- 24 mg/dl), coupled with a decrease in HDL cholesterol (49 +/- 4 vs 28 +/- 3 mg/dl). These data documenting high LDL cholesterol and low HDL cholesterol associated with an increased concentration and proportion of saturated fatty acids suggest that GSD-I patients on nocturnal intragastric feeding are at high risk for atherosclerosis and its complications.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3475522     DOI: 10.1007/BF02537265

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  33 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  Triglyceride clearing in glycogen storage disease.

Authors:  P P Forget; J Fernandes; P H Begemann
Journal:  Pediatr Res       Date:  1974-02       Impact factor: 3.756

3.  Studies in type I glycogenosis of the liver. The genesis and disposition of lactate.

Authors:  A Sadeghi-Nejad; E Presente; A Binkiewicz; B Senior
Journal:  J Pediatr       Date:  1974-07       Impact factor: 4.406

4.  Hyperlipemia in children with liver glycogen disease.

Authors:  J Fernandes; N A Pikaar
Journal:  Am J Clin Nutr       Date:  1969-05       Impact factor: 7.045

Review 5.  Effects of diet on lipoprotein metabolism.

Authors:  A C Goldberg; G Schonfeld
Journal:  Annu Rev Nutr       Date:  1985       Impact factor: 11.848

Review 6.  Synthetic substrates of lecithin: cholesterol acyltransferase.

Authors:  A Jonas
Journal:  J Lipid Res       Date:  1986-07       Impact factor: 5.922

7.  Removal defect of very-low-density lipoproteins from diabetic rats.

Authors:  H Bar-on; E Levy; Y Oschry; E Ziv; E Shafrir
Journal:  Biochim Biophys Acta       Date:  1984-03-27

Review 8.  Membrane lipid composition and cellular function.

Authors:  A A Spector; M A Yorek
Journal:  J Lipid Res       Date:  1985-09       Impact factor: 5.922

9.  Parenteral safflower oil emulsion (Liposyn 10%): safety and effectiveness in treating or preventing essential fatty acid deficiency in surgical patients.

Authors:  B A Bivins; R P Rapp; K Record; H C Meng; W O Griffen
Journal:  Ann Surg       Date:  1980-03       Impact factor: 12.969

10.  Relationships between pulmonary function and plasma fatty acid levels in cystic fibrosis patients.

Authors:  R A Gibson; J K Teubner; K Haines; D M Cooper; G P Davidson
Journal:  J Pediatr Gastroenterol Nutr       Date:  1986 May-Jun       Impact factor: 2.839

View more
  2 in total

1.  Angiotensin mediates renal fibrosis in the nephropathy of glycogen storage disease type Ia.

Authors:  W H Yiu; C-J Pan; R A Ruef; W-T Peng; M F Starost; B C Mansfield; J Y Chou
Journal:  Kidney Int       Date:  2007-12-12       Impact factor: 10.612

2.  Vascular dysfunction in glycogen storage disease type I.

Authors:  Angelina V Bernier; Catherine E Correia; Michael J Haller; Douglas W Theriaque; Jonathan J Shuster; David A Weinstein
Journal:  J Pediatr       Date:  2008-12-21       Impact factor: 4.406

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.